Anastrozole in Patients With Pulmonary Arterial Hypertension
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this clinical trial is to study the safety and efficacy of anastrozole in
adults diagnosed with pulmonary arterial hypertension (PAH). The study will evaluate how well
the drug is tolerated. The study will also evaluate if anastrozole effects estradiol (E2)
hormone levels, a sex hormone, and improves the function of the lower right chamber of the
heart (right ventricle).